Compare LNC & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LNC | CRL |
|---|---|---|
| Founded | 1905 | 1947 |
| Country | United States | United States |
| Employees | N/A | 19700 |
| Industry | Life Insurance | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 7.5B |
| IPO Year | N/A | 1999 |
| Metric | LNC | CRL |
|---|---|---|
| Price | $33.88 | $153.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $44.86 | ★ $197.58 |
| AVG Volume (30 Days) | ★ 2.5M | 874.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.36% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $11.02 | $2.11 |
| Revenue Next Year | $3.55 | $2.95 |
| P/E Ratio | $7.17 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $27.58 | $91.86 |
| 52 Week High | $46.82 | $228.88 |
| Indicator | LNC | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 39.92 | 35.37 |
| Support Level | $32.26 | $145.97 |
| Resistance Level | $35.54 | $157.42 |
| Average True Range (ATR) | 1.06 | 6.69 |
| MACD | 0.22 | -0.76 |
| Stochastic Oscillator | 54.84 | 10.53 |
Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.